Doxorubicin in combination with fluorouracil and cyclophosphamide (i.v. FAC regimen, day 1, 21) versus methotrexate in combination with fluorouracil and cyclophosphamide (i.v. CMF regimen, day 1, 21) as adjuvant chemotherapy for operable breast cancer: A study by the GEICAM group

  1. Martin, M.
  2. Villar, A.
  3. Sole-Calvo, A.
  4. Gonzalez, R.
  5. Massuti, B.
  6. Lizon, J.
  7. Camps, C.
  8. Carrato, A.
  9. Casado, A.
  10. Candel, M.T.
  11. Albanell, J.
  12. Aranda, J.
  13. Munarriz, B.
  14. Campbell, J.
  15. Diaz-Rubio, E.
Revue:
Annals of Oncology

ISSN: 0923-7534

Année de publication: 2003

Volumen: 14

Número: 6

Pages: 833-842

Type: Article

DOI: 10.1093/ANNONC/MDG260 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus